Apply topical GHK-Cu 1% on non-injection days
Collect all necessary items, such as a retatrutide pen (pre-filled syringe or vial as prescribed), an alcohol swab, a cotton ball or gauze pad, and a sharps disposal container for used needles
Please clarify the anemia type: a) Acute posthemorrhagic anemia (D62) b) Iron deficiency anemia secondary to chronic blood loss (D50.0) c) Iron deficiency anemia, unspecified (D50.9) d) Other please specify Clinical support: Hgb 8.9, ferritin 14, active GI bleed on EGD. Documented queries protect the practice during audits and support the specific code assigned
Where Human Evidence Is Still Limited Human evidence is limited for injectable GHK-Cu, systemic anti-aging, hair loss treatment, chronic disease treatment, liver repair, cognitive benefit, and broad regenerative medicine claims
BPC-157's gastric origin gives it natural relevance to gut research, and combination protocols with TB-500 have explored whether the actin-sequestering activity contributes additional benefit in intestinal anastomosis healing, fistula research, and gastric protection models